Adaptate Biotherapeutics
Latest round
- Series A
Last raised
- Apr 2021
Total raised
- $18M
Investors
- 2
About Adaptate Biotherapeutics
In January 2022, Takeda Pharmaceutical agreed to acquire Adaptate Biotherapeutics Ltd. Adaptate Biotherapeutics Ltd is focused on developing therapeutic antibodies to modulate the activity of gamma delta T cells located throughout the blood and tissues of the body. T cells recognize malignant cells by a pattern of markers expressed by dysregulated, transformed cells rather than any specific antigen. Following the acquisition, Adaptate Biotherapeutics Ltd is intended to further accelerate the development of T cell-based therapies.
Who invested in Adaptate Biotherapeutics
2 investors across 1 round
See all investors in Adaptate Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 19, 2021
Amount
$18M
Investors
Questions about Adaptate Biotherapeutics
Who invested in Adaptate Biotherapeutics?
Adaptate Biotherapeutics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Adaptate Biotherapeutics raised?
Adaptate Biotherapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Adaptate Biotherapeutics last raise money?
Adaptate Biotherapeutics's most recent round on record is a Series A, in Apr 2021.
What does Adaptate Biotherapeutics do?
In January 2022, Takeda Pharmaceutical agreed to acquire Adaptate Biotherapeutics Ltd.
Where is Adaptate Biotherapeutics headquartered?
Adaptate Biotherapeutics is headquartered in London, UK.
Which VCs invest in companies like Adaptate Biotherapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Adaptate Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Adaptate Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.